rosiglitazone has been researched along with Carotid Stenosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devergne, O; Heinz, P; Kempe, S; Kokai, E; Marx, N; Wirth, T | 1 |
| Bach, H; Bachem, M; Gizard, F; Haug, C; Hombach, V; Huber, R; Kapfer, X; Koenig, W; Marx, N; März, W; Meisner, F; Noak, A; Staels, B; Stojakovic, T; Sunder-Plassmann, L; Walcher, D | 1 |
| Clancy, P; Golledge, J; Mangan, S | 2 |
1 trial(s) available for rosiglitazone and Carotid Stenosis
| Article | Year |
|---|---|
Effect of rosiglitazone treatment on plaque inflammation and collagen content in nondiabetic patients: data from a randomized placebo-controlled trial.
Topics: Aged; Blood Glucose; Body Mass Index; C-Reactive Protein; Carotid Stenosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Collagen; Diabetes Mellitus; Female; Humans; Hypoglycemic Agents; Inflammation; Insulin; Male; Middle Aged; Rosiglitazone; Serum Amyloid A Protein; Thiazolidinediones | 2006 |
3 other study(ies) available for rosiglitazone and Carotid Stenosis
| Article | Year |
|---|---|
Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques.
Topics: Aorta; Atherosclerosis; Carotid Stenosis; Humans; Hypoglycemic Agents; Immunohistochemistry; Immunoprecipitation; Interleukins; Minor Histocompatibility Antigens; Myocytes, Smooth Muscle; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Thiazolidinediones; Transcription Factor RelA; Up-Regulation | 2009 |
Effects of peroxisome proliferator-activated receptor ligands in modulating tissue factor and tissue factor pathway inhibitor in acutely symptomatic carotid atheromas.
Topics: Aged; Aged, 80 and over; Carotid Stenosis; Female; Fenofibrate; Humans; Ischemic Attack, Transient; Ligands; Lipoproteins; Male; Middle Aged; Peroxisome Proliferator-Activated Receptors; PPAR alpha; PPAR gamma; Rosiglitazone; Signal Transduction; Stroke; Thiazolidinediones; Thromboplastin | 2007 |
Modulation of endothelial cell thrombomodulin by PPAR ligands--variation according to environment.
Topics: Aorta; Atherosclerosis; Blotting, Western; Carotid Stenosis; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Fenofibrate; Flow Cytometry; Humans; Ligands; Lipoproteins, LDL; Organ Culture Techniques; Rosiglitazone; Thiazolidinediones; Thrombomodulin; Ultraviolet Rays; Up-Regulation | 2008 |